XML 26 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Stock Option Plans
3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Option Plans
Stock Option Plans
In 2004, the Company has established a stock incentive plan (the "Plan"), as amended. Under the Plan, options were granted at an exercise price not less than the market value of the common stock on the date of grant and expire ten years from the date of grant. Officer options vest ratably over four years following the grant and are charged to expense using the straight-line method over the vesting period. Director options vest immediately and are charged to expense as of the date of grant. 
The following table summarizes the amount and activity of each grant with outstanding unexercised options, the total value and variables used in the computation and the amount expensed and included in general and administrative expense in the Consolidated Statements of Operations for the three months ended March 31, 2019.
 
  
Directors
 
 
Grant date
4/24/2009
5/7/2010
5/13/2011
5/4/2012
5/10/2013
5/9/2014
5/8/2015
5/6/2016
5/5/2017
5/11/2018
Subtotals
Total grant
32,500

32,500

32,500

35,000

35,000

30,000

35,000

32,500

27,500

27,500

320,000

Vested
32,500

32,500

32,500

35,000

35,000

30,000

35,000

32,500

27,500

27,500

320,000

Exercised
30,000

27,500

25,000

25,000

22,500

17,500

12,500

7,500


2,500

170,000

Forfeited

2,500

2,500




2,500

2,500

5,000


15,000

Exercisable at March 31, 2019
2,500

2,500

5,000

10,000

12,500

12,500

20,000

22,500

22,500

25,000

135,000

Remaining unexercised
2,500

2,500

5,000

10,000

12,500

12,500

20,000

22,500

22,500

25,000

135,000

Exercise price
$
32.68

$
38.76

$
41.82

$
39.29

$
44.42

$
47.03

$
51.07

$
57.74

$
59.41

$
49.46


Volatility
0.344

0.369

0.358

0.348

0.333

0.173

0.166

0.166

0.173

0.192


Expected life (years)
6.0

5.0

5.0

5.0

5.0

5.0

5.0

5.0

5.0

5.0


Assumed yield
4.54
%
4.23
%
4.16
%
4.61
%
4.53
%
4.48
%
4.54
%
3.75
%
3.45
%
3.70
%

Risk-free rate
2.19
%
2.17
%
1.86
%
0.78
%
0.82
%
1.63
%
1.50
%
1.23
%
1.89
%
2.84
%

Total value at grant date
$
222,950

$
287,950

$
297,375

$
257,250

$
278,250

$
109,500

$
125,300

$
151,125

$
165,550

$
169,400

$
2,064,650

Expensed in previous years
222,950

287,950

297,375

257,250

278,250

109,500

125,300

151,125

165,550

169,400

2,064,650

Expensed in 2019











Future expense











 
Officers
 
 
 
 
Grant date
5/13/2011
5/4/2012
5/10/2013
5/9/2014
5/8/2015
5/6/2016
5/5/2017
5/11/2018
Subtotal
 
Grand 
Totals
Total grant
162,500

242,500

202,500

170,000

190,000

194,000

205,000

217,500

1,584,000

 
1,904,000

Vested
118,750

107,500

171,875

168,125

140,625

96,375

51,250


854,500

 
1,174,500

Exercised
103,750

92,455

129,375

46,126

20,625

3,750



396,081

 
566,081

Forfeited
43,750

135,000

30,625

1,875

3,125

1,875



216,250

 
231,250

Exercisable at March 31, 2019
15,000

15,045

42,500

121,999

120,000

92,625

51,250


458,419

 
593,419

Remaining unexercised
15,000

15,045

42,500

121,999

166,250

188,375

205,000

217,500

971,669

 
1,106,669

Exercise price
$
41.82

$
39.29

$
44.42

$
47.03

$
51.07

$
57.74

$
59.41

$
49.46

 
 
 
Volatility
0.330

0.315

0.304

0.306

0.298

0.185

0.170

0.177

 
 
 
Expected life (years)
8.0

8.0

8.0

7.0

7.0

7.0

7.0

7.0

 
 
 
Assumed yield
4.81
%
5.28
%
5.12
%
4.89
%
4.94
%
3.80
%
3.50
%
3.75
%
 
 
 
Risk-free rate
2.75
%
1.49
%
1.49
%
2.17
%
1.89
%
1.55
%
2.17
%
2.94
%
 
 
 
Gross value at grant date
$
1,366,625

$
1,518,050

$
1,401,300

$
1,349,800

$
1,584,600

$
1,136,840

$
1,324,300

$
1,313,700

$
10,995,215

 
$
13,059,865

Estimated forfeitures
367,937

845,100

211,925

14,887

26,062

86,628

91,642

83,157

1,727,338

 
1,727,338

Expensed in previous years
998,688

672,950

1,189,375

1,334,913

1,322,596

700,128

513,600

205,088

6,937,338

 
9,001,988

Expensed in 2019




176,957

65,637

77,040

76,908

396,542

 
396,542

Future expense




58,985

284,447

642,018

948,547

1,933,997

 
1,933,997

Weighted average term of remaining future expense (in years)
2.4

 
 
 
 
 
 
 
 
 
 

 
The table below summarizes the option activity for the three months ended March 31, 2019:
 
 
Number of
Shares
 
Weighted
Average
Exercise Price
per share
 
Aggregate
Intrinsic Value
Outstanding at January 1
 
1,114,169

 
$
52.40

 
$
543,662

Granted
 

 

 

Exercised
 

 

 

Expired/Forfeited
 
(7,500
)
 
56.07

 

Outstanding at March 31
 
1,106,669

 
52.38

 
2,056,820

Exercisable at March 31
 
593,419

 
50.86

 
1,627,519


The intrinsic value measures the price difference between the options’ exercise price and the closing share price quoted by the New York Stock Exchange as of the date of measurement. The intrinsic value for shares exercised during the period was calculated by using the closing share price on the date of exercise. At March 29, 2019, the final trading day of the first quarter, the closing share price of $51.37 was lower than the exercise price of the 210,875 and 227,500 outstanding options granted in 2016 and 2017, respectively. The weighted average remaining contractual life of the Company’s outstanding and exercisable options is 7.0 years and 6.0 years, respectively.